Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Auriane Gamelin
COO
agamelin@oncoxome.com

Message the company or request a 1:1 meeting here

OncoXome is an oncology startup whose objective is to bring to patients with advanced cancer an innovative multitarget therapeutic approach hacking cell communication and using gene editing to overcome cancer resistance.

Our approach is to “hack” this communication system in order to manipulate and control cancer outcomes. Through our three platforms combining CRISPR gene editing therapy, our specific delivery system, and our large-scale exosome supply, we knockout driving oncogenes, inducing cancer cell death and preventing cancer resistance.

We first target patients with advanced KRAS mutated pancreatic, colorectal and lung cancers.

Pitch Video

Slide Deck

Executive Summary